Egr-1 upregulates siva-1 expression and induces cardiac fibroblast apoptosis

International Journal of Molecular Sciences

Volumn 15, Issue 1, 2014, Pages 1538-1553

  Zins, Karin ^a   Pomyje, Jiri ^b   Hofer, Erhard ^b   Abraham, Dietmar ^a   Lucas, Trevor ^a   Aharinejad, Seyedhossein ^a  

^a Medical University of Vienna   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Cardiac fibroblasts; Egr 1; Gene expression; Siva 1; Transcription factor

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; EARLY GROWTH RESPONSE FACTOR 1; SIVA 1 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; EARLY GROWTH RESPONSE PROTEIN 1; FIBROBLASTS; HEART VENTRICLES; HUMANS; RNA, MESSENGER; UP-REGULATION;

EID: 84892882004     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15011538     Document Type: Article

References (67)

1. Porter, K.E.; Turner, N.A. Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123, 255-278.
2. Brown, R.D.; Ambler, S.K.; Mitchell, M.D.; Long, C.S. The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 657-687.
3. Weber, K.T. Fibrosis in hypertensive heart disease: Focus on cardiac fibroblasts. J. Hypertens 2004, 22, 47-50.
4. Baudino, T.A.; Carver, W.; Giles, W.; Borg, T.K. Cardiac fibroblasts: Friend or foe? Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H1015-H1026.
5. Souders, C.A.; Bowers, S.L.; Baudino, T.A. Cardiac fibroblast: The renaissance cell. Circ. Res. 2009, 105, 1164-1176.
6. Takano, H.; Hasegawa, H.; Nagai, T.; Komuro, I. Implication of cardiac remodeling in heart failure: Mechanisms and therapeutic strategies. Intern. Med. 2003, 42, 465-469.
7. Spinale, F.G. Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol. Rev. 2007, 87, 1285-1342.
8. Der Sarkissian, S.; Marchand, E.L.; Duguay, D.; Hamet, P.; de Blois, D. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril. Cardiovasc. Res. 2003, 57, 775-783.
9. Duguay, D.; Pesant, S.; Deschepper, C.F.; deBlois, D. Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine. J. Hypertens. 2007, 25, 1291-1299.
10. Takeda, N.; Manabe, I.; Uchino, Y.; Eguchi, K.; Matsumoto, S.; Nishimura, S.; Shindo, T.; Sano, M.; Otsu, K.; Snider, P., et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Invest. 2010, 120, 254-265.
11. Creemers, E.E.; Pinto, Y.M. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc. Res. 2011, 89, 265-272.
12. Tijsen, A.J.; Pinto, Y.M.; Creemers, E.E. Non-cardiomyocyte microRNAs in heart failure. Cardiovasc. Res. 2012, 93, 573-582.
13. Kumar, S. Caspase function in programmed cell death. Cell Death Differ. 2007, 14, 32-43.
14. Logue, S.E.; Martin, S.J. Caspase activation cascades in apoptosis. Biochem. Soc. Trans. 2008, 36, 1-9.
15. Kumar, S.; Cakouros, D. Transcriptional control of the core cell-death machinery. Trends Biochem. Sci. 2004, 29, 193-199.
16. Hengartner, M.O. The biochemistry of apoptosis. Nature 2000, 407, 770-776.
17. Gustafsson, A.B.; Gottlieb, R.A. Mechanisms of apoptosis in the heart. J. Clin. Immunol. 2003, 23, 447-459.
18. Saraste, A.; Pulkki, K.; Kallajoki, M.; Heikkila, P.; Laine, P.; Mattila, S.; Nieminen, M.S.; Parvinen, M.; Voipio-Pulkki, L.M. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur. J. Clin. Invest. 1999, 29, 380-386.
19. Takemura, G.; Ohno, M.; Hayakawa, Y.; Misao, J.; Kanoh, M.; Ohno, A.; Uno, Y.; Minatoguchi, S.; Fujiwara, T.; Fujiwara, H. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ. Res. 1998, 82, 1130-1138.
20. Park, M.; Shen, Y.T.; Gaussin, V.; Heyndrickx, G.R.; Bartunek, J.; Resuello, R.R.; Natividad, F.F.; Kitsis, R.N.; Vatner, D.E.; Vatner, S.F. Apoptosis predominates in nonmyocytes in heart failure. Am. J. Physiol. Heart Circ. Physiol. 2009, 297, H785-H791.
21. Milbrandt, J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 1987, 238, 797-799.
22. Bhattacharyya, S.; Fang, F.; Tourtellotte, W.; Varga, J. Egr-1: New conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J. Pathol. 2013, 229, 286-297.
23. Thiel, G.; Cibelli, G. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell. Physiol. 2002, 193, 287-292.
24. Fu, J.D.; Stone, N.R.; Liu, L.; Spencer, C.I.; Qian, L.; Hayashi, Y.; Delgado-Olguin, P.; Ding, S.; Bruneau, B.G.; Srivastava, D. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Reports 2013, 1, 235-247.
25. Christy, B.A.; Lau, L.F.; Nathans, D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc. Natl. Acad. Sci. USA 1988, 85, 7857-7861.
26. Lim, R.W.; Varnum, B.C.; O'Brien, T.G.; Herschman, H.R. Induction of tumor promotor-inducible genes in murine 3T3 cell lines and tetradecanoyl phorbol acetate-nonproliferative 3T3 variants can occur through protein kinase C-dependent and -independent pathways. Mol. Cell. Biol. 1989, 9, 1790-1793.
27. Lemaire, P.; Vesque, C.; Schmitt, J.; Stunnenberg, H.; Frank, R.; Charnay, P. The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator. Mol. Cell. Biol. 1990, 10, 3456-3467.
28. Lucerna, M.; Pomyje, J.; Mechtcheriakova, D.; Kadl, A.; Gruber, F.; Bilban, M.; Sobanov, Y.; Schabbauer, G.; Breuss, J.; Wagner, O., et al. Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. Cancer Res. 2006, 66, 6708-6713.
29. Fu, M.; Zhu, X.; Zhang, J.; Liang, J.; Lin, Y.; Zhao, L.; Ehrengruber, M.U.; Chen, Y.E. Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene 2003, 315, 33-41.
30. Swirnoff, A.H.; Milbrandt, J. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol. Cell. Biol. 1995, 15, 2275-2287.
31. Christy, B.; Nathans, D. DNA binding site of the growth factor-inducible protein Zif268. Proc. Natl. Acad. Sci. USA 1989, 86, 8737-8741.
32. Cao, X.; Mahendran, R.; Guy, G.R.; Tan, Y.H. Detection and characterization of cellular EGR-1 binding to its recognition site. J. Biol. Chem. 1993, 268, 16949-16957.
33. Svaren, J.; Sevetson, B.R.; Apel, E.D.; Zimonjic, D.B.; Popescu, N.C.; Milbrandt, J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 1996, 16, 3545-3553.
34. Kumbrink, J.; Gerlinger, M.; Johnson, J.P. Egr-1 induces the expression of its corepressor Nab2 by activation of the Nab2 promoter thereby establishing a negative feedback loop. J. Biol. Chem. 2005, 280, 42785-42793.
35. Khachigian, L.M. Early growth response-1 in cardiovascular pathobiology. Circ. Res. 2006, 98, 186-191.
36. Rayner, B.S.; Figtree, G.A.; Sabaretnam, T.; Shang, P.; Mazhar, J.; Weaver, J.C.; Lay, W.N.; Witting, P.K.; Hunyor, S.N.; Grieve, S.M.; et al. Selective inhibition of the master regulator transcription factor Egr-1 with catalytic oligonucleotides reduces myocardial injury and improves left ventricular systolic function in a preclinical model of myocardial infarction. J. Am. Heart Assoc. 2013, 2, e000023.
37. Harja, E.; Bucciarelli, L.G.; Lu, Y.; Stern, D.M.; Zou, Y.S.; Schmidt, A.M.; Yan, S.F. Early growth response-1 promotes atherogenesis: Mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ. Res. 2004, 94, 333-339.
38. Fahmy, R.G.; Dass, C.R.; Sun, L.Q.; Chesterman, C.N.; Khachigian, L.M. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat. Med. 2003, 9, 1026-1032.
39. Arai, M.; Yoguchi, A.; Takizawa, T.; Yokoyama, T.; Kanda, T.; Kurabayashi, M.; Nagai, R. Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca2+-ATPase gene transcription. Circ. Res. 2000, 86, 8-14.
40. Bhindi, R.; Khachigian, L.M.; Lowe, H.C. DNAzymes targeting the transcription factor Egr-1 reduce myocardial infarct size following ischemia-reperfusion in rats. J. Thromb. Haemost. 2006, 4, 1479-1483.
41. Kwon, O.; Soung, N.K.; Thimmegowda, N.R.; Jeong, S.J.; Jang, J.H.; Moon, D.O.; Chung, J.K.; Lee, K.S.; Kwon, Y.T.; Erikson, R.L., et al. Patulin induces colorectal cancer cells apoptosis through EGR-1 dependent ATF3 up-regulation. Cell Signal 2012, 24, 943-950.
42. Deblois, D.; Tea, B.S.; Beaudry, D.; Hamet, P. Regulation of therapeutic apoptosis: A potential target in controlling hypertensive organ damage. Can. J. Physiol. Pharmacol. 2005, 83, 29-41.
43. Henke, A.; Launhardt, H.; Klement, K.; Stelzner, A.; Zell, R.; Munder, T. Apoptosis in coxsackievirus B3-caused diseases: Interaction between the capsid protein VP2 and the proapoptotic protein siva. J. Virol. 2000, 74, 4284-4290.
44. Smiley, S.T.; Reers, M.; Mottola-Hartshorn, C.; Lin, M.; Chen, A.; Smith, T.W.; Steele, G.D., Jr.; Chen, L.B. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA 1991, 88, 3671-3675.
45. Prasad, K.V.; Ao, Z.; Yoon, Y.; Wu, M.X.; Rizk, M.; Jacquot, S.; Schlossman, S.F. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. USA 1997, 94, 6346-6351.
46. Py, B.; Slomianny, C.; Auberger, P.; Petit, P.X.; Benichou, S. Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. J. Immunol. 2004, 172, 4008-4017.
47. Mei, Y.; Wu, M. Multifaceted functions of Siva-1: More than an Indian god of destruction. Protein Cell 2012, 3, 117-122.
48. Fortin, A.; MacLaurin, J.G.; Arbour, N.; Cregan, S.P.; Kushwaha, N.; Callaghan, S.M.; Park, D.S.; Albert, P.R.; Slack, R.S. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J. Biol. Chem. 2004, 279, 28706-28714.
49. Xiao, H.; Palhan, V.; Yang, Y.; Roeder, R.G. TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes. EMBO J. 2000, 19, 956-963.
50. Svaren, J.; Sevetson, B.R.; Golda, T.; Stanton, J.J.; Swirnoff, A.H.; Milbrandt, J. Novel mutants of NAB corepressors enhance activation by Egr transactivators. EMBO J. 1998, 17, 6010-6019.
51. Saadane, N.; Alpert, L.; Chalifour, L.E. Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 2000, 278, H796-805.
52. Autieri, M.V.; Kelemen, S.E.; Gaughan, J.P.; Eisen, H.J. Early growth responsive gene (Egr)-1 expression correlates with cardiac allograft rejection. Transplantation 2004, 78, 107-111.
53. Okada, M.; Wang, C.Y.; Hwang, D.W.; Sakaguchi, T.; Olson, K.E.; Yoshikawa, Y.; Minamoto, K.; Mazer, S.P.; Yan, S.F.; Pinsky, D.J. Transcriptional control of cardiac allograft vasculopathy by early growth response gene-1 (Egr-1). Circ. Res. 2002, 91, 135-142.
54. Zhang, Y.; Shi, G.; Zheng, J.; Tang, Z.; Gao, P.; Lv, Y.; Guo, F.; Jia, Q. The protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rats by inhibiting Egr-1 overexpression. Cell. Physiol. Biochem. 2007, 20, 639-648.
55. Khachigian, L.M. Suppressing a sick heart. Nat. Med. 2005, 11, 828-829.
56. Buitrago, M.; Lorenz, K.; Maass, A.H.; Oberdorf-Maass, S.; Keller, U.; Schmitteckert, E.M.; Ivashchenko, Y.; Lohse, M.J.; Engelhardt, S. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat. Med. 2005, 11, 837-844.
57. Tsai, J.C.; Liu, L.; Cooley, B.C.; DiChiara, M.R.; Topper, J.N.; Aird, W.C. The Egr-1 promoter contains information for constitutive and inducible expression in transgenic mice. FASEB J. 2000, 14, 1870-1872.
58. Wang, C.; Dostanic, S.; Servant, N.; Chalifour, L.E. Egr-1 negatively regulates expression of the sodium-calcium exchanger-1 in cardiomyocytes in vitro and in vivo. Cardiovasc. Res. 2005, 65, 187-194.
59. Lee, S.L.; Tourtellotte, L.C.; Wesselschmidt, R.L.; Milbrandt, J. Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J. Biol. Chem. 1995, 270, 9971-9977.
60. Chu, F.; Borthakur, A.; Sun, X.; Barkinge, J.; Gudi, R.; Hawkins, S.; Prasad, K.V. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Apoptosis 2004, 9, 83-95.
61. Cao, C.; Ren, X.; Kharbanda, S.; Koleske, A.; Prasad, K.V.; Kufe, D. The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress. J. Biol. Chem. 2001, 276, 11465-11468.
62. Lucerna, M.; Mechtcheriakova, D.; Kadl, A.; Schabbauer, G.; Schafer, R.; Gruber, F.; Koshelnick, Y.; Muller, H.D.; Issbrucker, K.; Clauss, M. et al. NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. J. Biol. Chem. 2003, 278, 11433-11440.
63. Gomez-Foix, A.M.; Coats, W.S.; Baque, S.; Alam, T.; Gerard, R.D.; Newgard, C.B. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem. 1992, 267, 25129-25134.
64. Quandt, K.; Frech, K.; Karas, H.; Wingender, E.; Werner, T. MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995, 23, 4878-4884.
65. Schafer, R.; Abraham, D.; Paulus, P.; Blumer, R.; Grimm, M.; Wojta, J.; Aharinejad, S. Impaired VE-cadherin/β-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Circulation 2003, 108, 1585-1591.
66. Paulus, P.; Stanley, E.R.; Schafer, R.; Abraham, D.; Aharinejad, S. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res. 2006, 66, 4349-4356.
67. Abraham, D.; Hofbauer, R.; Schafer, R.; Blumer, R.; Paulus, P.; Miksovsky, A.; Traxler, H.; Kocher, A.; Aharinejad, S. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ. Res. 2000, 87, 644-647.